menu
    • menu

    Company profile for CellProthera

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CellProthera is a biotechnology company that has pioneered a novel therapeutic approach for the structural and functional regeneration of severe cardiac lesions resulting from myocardial infarctions. Following the receipt of European and national (FR/GB) regulatory approvals, CellProthera has initiated its Phase I/IIb clinical trials in humans.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CellProtheraFrance Flag
    Country
    Country
    France
    Address
    Address
    12 rue du Parc 68100 MULHOUSE
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cellprothera.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CellProthera, Quintessence Partner on Cell Therapy Manufacturing
    CellProthera, Quintessence Partner on Cell Therapy Manufacturing

    28 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-28/cellprothera-collaborates-with-quintessence-biotech-to-industrialize-cell-manufacturing-processes-ahead-of-stroke-clinical-trials

    PHARMIWEB
    28 Apr 2026
    Share Share
    Celyad Oncology Announces The Sale Of C-Cathez Catheter
    Celyad Oncology Announces The Sale Of C-Cathez Catheter

    12 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-12/celyad-oncology-announces-the-sale-of-c-cathez-catheter

    PHARMIWEB
    12 Feb 2026
    Share Share
    CellProthera Publishes Phase I/IIb Results on ProtheraCytes
    CellProthera Publishes Phase I/IIb Results on ProtheraCytes

    10 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-10/cellprothera-announces-peer-reviewed-publication-of-its-phase-iiib-results-on-safety-and-feasibility-of-protheracytes-in-patients-with-severe-heart

    PHARMAWEB
    10 Sep 2025
    Share Share
    CellProthera chooses CELLforCURE by Seqens for Ph 3 Manufactiring
    CellProthera chooses CELLforCURE by Seqens for Ph 3 Manufactiring

    21 May 2025

    // PRESS RELEASE

    https://www.seqens.com/cellprothera-selects-cellforcure-by-seqens-for-phase-3-gmp-manufacturing/

    PRESS RELEASE
    21 May 2025
    Share Share
    CellProthera Signs MOU with Shonan Kamakura for StemXpand® Trial
    CellProthera Signs MOU with Shonan Kamakura for StemXpand® Trial

    12 Dec 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-12-12/cellprothera-signs-mou-with-shonan-kamakura-general-hospital-for-use-of-stemxpand-in-japanese-stem-cell-clinical-trial

    PHARMAWEB
    12 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search